
Gilead Sciences, Inc.
Gilead Sciences, Inc. (GILD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GILD · as of Jun 8, 2026
Key Statistics
Explore Gilead Sciences, Inc. Data
gild stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 58 · Buy rate: 67.2%
The GILD analyst consensus is Buy, based on ratings from 58 Wall Street analysts over the past 3 months. The average 12-month price target is $159.56, representing +23.54% upside from the current price of $129.16.
Competitors & Peers
gild competitorsStock Performance
Full HistoryAbout Gilead Sciences, Inc.
Gilead Sciences, Inc. a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company …
what is gilead sciences, inc. · gild stock overview · gilead sciences, inc. company profile · who is gilead sciences, inc. ceo · gild NASDAQ · gilead sciences, inc. headquarters · gilead sciences, inc. business segments
About Stock Overview & Key Data
Gilead Sciences, Inc. (GILD) is a Healthcare company in the Drug Manufacturers - General industry, listed on NASDAQ since Jan 22, 1992. As of the latest trading session, GILD stock price is $129.16, with a market capitalization of $160.4B. The stock has returned +14.30% over the past 12 months and +5.23% year-to-date.
According to 58 Wall Street analysts, the consensus rating for Gilead Sciences, Inc. stock is Buy, with an average 12-month price target of $159.56. In fiscal year 2025, Gilead Sciences, Inc. reported revenue of $29.4B and net income of $8.5B. For detailed data — including Gilead Sciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Gilead Sciences, Inc. (GILD) stock price is $129.16. The stock is traded on NASDAQ under the ticker symbol GILD. The 52-week range is $104.46 – $157.29.